Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Evaluating the diagnostic accuracy of maximal aortic diameter, length and volume for prediction of aortic dissection.

Heuts S, Adriaans BP, Rylski B, Mihl C, Bekkers SCAM, Olsthoorn JR, Natour E, Bouman H, Berezowski M, Kosiorowska K, Crijns HJGM, Maessen JG, Wildberger J, Schalla S, Sardari Nia P.

Heart. 2020 Mar 8. pii: heartjnl-2019-316251. doi: 10.1136/heartjnl-2019-316251. [Epub ahead of print]

PMID:
32152004
2.

Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction.

Smulders MW, Kietselaer BLJH, Wildberger JE, Dagnelie PC, Brunner-La Rocca HP, Mingels AMA, van Cauteren YJM, Theunissen RALJ, Post MJ, Schalla S, van Kuijk SMJ, Das M, Kim RJ, Crijns HJGM, Bekkers SCAM.

J Am Coll Cardiol. 2019 Nov 19;74(20):2466-2477. doi: 10.1016/j.jacc.2019.09.027.

PMID:
31727284
3.

Predictive imaging for thoracic aortic dissection and rupture: moving beyond diameters.

Adriaans BP, Wildberger JE, Westenberg JJM, Lamb HJ, Schalla S.

Eur Radiol. 2019 Dec;29(12):6396-6404. doi: 10.1007/s00330-019-06320-7. Epub 2019 Jul 5. Review.

4.

Clinical assessment of aortic valve stenosis: Comparison between 4D flow MRI and transthoracic echocardiography.

Adriaans BP, Westenberg JJM, van Cauteren YJM, Gerretsen S, Elbaz MSM, Bekkers SCAM, Veenstra LF, Crijns HJGM, Wildberger JE, Schalla S.

J Magn Reson Imaging. 2020 Feb;51(2):472-480. doi: 10.1002/jmri.26847. Epub 2019 Jun 30.

5.

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study.

Gulpen AJW, Ten Cate H, Henskens YMC, van Oerle R, Wetzels R, Schalla S, Crijns HJ, Ten Cate-Hoek AJ.

PLoS One. 2019 Jun 6;14(6):e0217302. doi: 10.1371/journal.pone.0217302. eCollection 2019.

6.

Adding Speckle-Tracking Echocardiography to Visual Assessment of Systolic Wall Motion Abnormalities Improves the Detection of Myocardial Infarction.

van Mourik MJW, Zaar DVJ, Smulders MW, Heijman J, Lumens J, Dokter JE, Lima Passos V, Schalla S, Knackstedt C, Schummers G, Gjesdal O, Edvardsen T, Bekkers SCAM.

J Am Soc Echocardiogr. 2019 Jan;32(1):65-73. doi: 10.1016/j.echo.2018.09.007. Epub 2018 Oct 17.

PMID:
30340888
7.

Aortic elongation part II: the risk of acute type A aortic dissection.

Heuts S, Adriaans BP, Gerretsen S, Natour E, Vos R, Cheriex EC, Crijns HJGM, Wildberger JE, Maessen JG, Schalla S, Sardari Nia P.

Heart. 2018 Nov;104(21):1778-1782. doi: 10.1136/heartjnl-2017-312867. Epub 2018 Mar 28.

PMID:
29593079
8.

Aortic elongation part I: the normal aortic ageing process.

Adriaans BP, Heuts S, Gerretsen S, Cheriex EC, Vos R, Natour E, Maessen JG, Sardari Nia P, Crijns HJGM, Wildberger JE, Schalla S.

Heart. 2018 Nov;104(21):1772-1777. doi: 10.1136/heartjnl-2017-312866. Epub 2018 Mar 28.

PMID:
29593078
9.

Bicuspid Aortic Valve Stenosis and the Effect of Vitamin K2 on Calcification Using 18F-Sodium Fluoride Positron Emission Tomography/Magnetic Resonance: The BASIK2 Rationale and Trial Design.

Peeters FECM, van Mourik MJW, Meex SJR, Bucerius J, Schalla SM, Gerretsen SC, Mihl C, Dweck MR, Schurgers LJ, Wildberger JE, Crijns HJGM, Kietselaer BLJH.

Nutrients. 2018 Mar 21;10(4). pii: E386. doi: 10.3390/nu10040386.

10.

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation.

Henskens YMC, Gulpen AJW, van Oerle R, Wetzels R, Verhezen P, Spronk H, Schalla S, Crijns HJ, Ten Cate H, Ten Cate-Hoek A.

Thromb J. 2018 Feb 1;16:3. doi: 10.1186/s12959-017-0160-2. eCollection 2018.

11.

Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias.

Verdonschot JAJ, Hazebroek MR, Derks KWJ, Barandiarán Aizpurua A, Merken JJ, Wang P, Bierau J, van den Wijngaard A, Schalla SM, Abdul Hamid MA, van Bilsen M, van Empel VPM, Knackstedt C, Brunner-La Rocca HP, Brunner HG, Krapels IPC, Heymans SRB.

Eur Heart J. 2018 Mar 7;39(10):864-873. doi: 10.1093/eurheartj/ehx808.

PMID:
29377983
12.

Non-invasive assessment of microvascular dysfunction in patients with microvascular angina.

Jaarsma C, Vink H, van Haare J, Bekkers SCAM, van Rooijen BD, Backes WH, Wildberger JE, Crijns HJ, van Teeffelen J, Schalla S.

Int J Cardiol. 2017 Dec 1;248:433-439. doi: 10.1016/j.ijcard.2017.05.010. Epub 2017 Jul 18.

13.

Body Shape and Weight Loss as Motivators for Breastfeeding Initiation and Continuation.

Schalla SC, Witcomb GL, Haycraft E.

Int J Environ Res Public Health. 2017 Jul 11;14(7). pii: E754. doi: 10.3390/ijerph14070754.

14.

Comparison of the prognostic value of negative non-invasive cardiac investigations in patients with suspected or known coronary artery disease-a meta-analysis.

Smulders MW, Jaarsma C, Nelemans PJ, Bekkers SCAM, Bucerius J, Leiner T, Crijns HJGM, Wildberger JE, Schalla S.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):980-987. doi: 10.1093/ehjci/jex014. Review.

PMID:
28329376
15.

Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?

Smulders MW, Kietselaer BL, Schalla S, Bucerius J, Jaarsma C, van Dieijen-Visser MP, Mingels AM, Rocca HP, Post M, Das M, Crijns HJ, Wildberger JE, Bekkers SC.

Am Heart J. 2016 Jul;177:102-11. doi: 10.1016/j.ahj.2016.03.025. Epub 2016 Apr 30. Review.

16.

Cardiac shockwave therapy in patients with chronic refractory angina pectoris.

Vainer J, Habets JH, Schalla S, Lousberg AH, de Pont CD, Vöö SA, Brans BT, Hoorntje JC, Waltenberger J.

Neth Heart J. 2016 May;24(5):343-9. doi: 10.1007/s12471-016-0821-y.

17.

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.

Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, Merken J, Kuznetsova T, Staessen JA, Brunner-La Rocca HP, van Paassen P, Cohen Tervaert JW, Heymans S.

Int J Cardiol. 2015 Nov 15;199:170-9. doi: 10.1016/j.ijcard.2015.06.087. Epub 2015 Jul 15.

PMID:
26209947
18.

Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging.

Schalla S, Jaarsma C, Bekkers SC, Waltenberger J, Dennert R, Crijns HJ, Wildberger J, Heymans S, Brunner-La Rocca HP.

Neth Heart J. 2015 Apr;23(4):232-40. doi: 10.1007/s12471-015-0673-x.

19.

Severe mitral regurgitation caused by eosinophilic endocarditis.

van Dongen IM, van Kraaij DJW, Schalla S, Brunner-La Rocca HP, Driessen RGH.

J Cardiol Cases. 2014 Jul 7;10(3):108-110. doi: 10.1016/j.jccase.2014.05.012. eCollection 2014 Sep.

20.

Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies.

El Aidi H, Adams A, Moons KG, Den Ruijter HM, Mali WP, Doevendans PA, Nagel E, Schalla S, Bots ML, Leiner T.

J Am Coll Cardiol. 2014 Mar 25;63(11):1031-45. doi: 10.1016/j.jacc.2013.11.048. Epub 2014 Jan 30. Review.

21.

The role of cardiovascular magnetic resonance imaging and computed tomography angiography in suspected non-ST-elevation myocardial infarction patients: design and rationale of the CARdiovascular Magnetic rEsoNance imaging and computed Tomography Angiography (CARMENTA) trial.

Smulders MW, Kietselaer BL, Das M, Wildberger JE, Crijns HJ, Veenstra LF, Brunner-La Rocca HP, van Dieijen-Visser MP, Mingels AM, Dagnelie PC, Post MJ, Gorgels AP, van Asselt AD, Vogel G, Schalla S, Kim RJ, Bekkers SC.

Am Heart J. 2013 Dec;166(6):968-75. doi: 10.1016/j.ahj.2013.09.012. Epub 2013 Oct 23.

22.

Comparison of different electrocardiographic scoring systems for detection of any previous myocardial infarction as assessed with cardiovascular magnetic resonance imaging.

Jaarsma C, Bekkers SC, Haidari Z, Smulders MW, Nelemans PJ, Gorgels AP, Crijns HJ, Wildberger JE, Schalla S.

Am J Cardiol. 2013 Oct 15;112(8):1069-74. doi: 10.1016/j.amjcard.2013.05.048. Epub 2013 Jul 2.

PMID:
23827406
23.

Incremental value of cardiovascular magnetic resonance over echocardiography in the detection of acute and chronic myocardial infarction.

Jaarsma C, Schalla S, Cheriex EC, Smulders MW, van Dongen I, Nelemans PJ, Gorgels AP, Wildberger JE, Crijns HJ, Bekkers SC.

J Cardiovasc Magn Reson. 2013 Jan 16;15:5. doi: 10.1186/1532-429X-15-5.

24.

Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study.

Hermans MC, Faber CG, Bekkers SC, de Die-Smulders CE, Gerrits MM, Merkies IS, Snoep G, Pinto YM, Schalla S.

J Cardiovasc Magn Reson. 2012 Jul 24;14:48. doi: 10.1186/1532-429X-14-48.

25.

Evaluation of the electrocardiogram in identifying and quantifying lateral involvement in nonanterior wall infarction using cardiovascular magnetic resonance imaging.

van der Weg K, Bekkers SC, Winkens B, Lemmert ME, Schalla S, Crijns HJ, Waltenberger J, Gorgels AP.

J Electrocardiol. 2012 Sep;45(5):478-84. doi: 10.1016/j.jelectrocard.2012.04.008. Epub 2012 May 18.

26.
27.

The relationships between cardiovascular magnetic resonance imaging variables of acute myocardial infarction and both left ventricular dysfunction and immediate postreperfusion ST segment recovery.

Bekkers SC, Lemmert ME, Passos VL, Mihl C, Schalla S, Wildberger JE, Waltenberger J, Gorgels AP.

J Electrocardiol. 2011 Sep-Oct;44(5):561-7. doi: 10.1016/j.jelectrocard.2011.07.006.

PMID:
21872003
28.

Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers.

van Rijsingen IA, Bekkers SC, Schalla S, Hermans-van Ast JF, Snoep G, Alzand BS, Arens YH, van den Wijngaard A, Crijns HJ, Pinto YM.

Neth Heart J. 2011 Apr;19(4):168-174. Epub 2011 Feb 17.

29.

Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging.

Gerretsen SC, Kooi ME, Kessels AG, Schalla S, Katoh M, van der Geest RJ, Manning WJ, Waltenberger J, van Engelshoven JM, Botnar RM, Leiner T.

PLoS One. 2010 Sep 29;5(9). pii: e12998. doi: 10.1371/journal.pone.0012998.

30.

Never-changing mediastinal nodules.

Schalla S, Walenkamp G, Opdenakker L, Maessen J.

Eur J Cardiothorac Surg. 2011 May;39(5):796. doi: 10.1016/j.ejcts.2010.08.026. Epub 2010 Sep 29. No abstract available.

PMID:
20884222
31.

Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging.

Verjans J, Wolters S, Laufer W, Schellings M, Lax M, Lovhaug D, Boersma H, Kemerink G, Schalla S, Gordon P, Teule J, Narula J, Hofstra L.

J Nucl Cardiol. 2010 Dec;17(6):1065-72. doi: 10.1007/s12350-010-9268-5. Epub 2010 Jul 24.

32.

Images in cardiovascular medicine: Retrograde flow in the descending thoracic aorta: magnetic resonance imaging of an apicoaortic conduit.

Jaarsma C, Nijs J, Gommers S, Bekkers SC, Schalla S.

Circulation. 2010 Jul 13;122(2):e12. doi: 10.1161/CIRCULATIONAHA.109.935379. No abstract available.

PMID:
20625138
33.

Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.

Dennert R, Velthuis S, Westermann D, Donker D, Schalla S, van Suylen RJ, Heymans S.

Antivir Ther. 2010;15(4):681-5. doi: 10.3851/IMP1563.

PMID:
20587861
34.

Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging.

Bekkers SC, Smulders MW, Passos VL, Leiner T, Waltenberger J, Gorgels AP, Schalla S.

Eur Radiol. 2010 Nov;20(11):2572-8. doi: 10.1007/s00330-010-1849-9. Epub 2010 Jun 26.

35.

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.

Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen RJ, van Paassen P, Tervaert JW, Wolffs P, Goossens VJ, Bruggeman C, Waltenberger J, Crijns HJ, Heymans S.

Antivir Ther. 2010;15(2):193-201. doi: 10.3851/IMP1516.

PMID:
20386074
36.

Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy.

Schalla S, Bekkers SC, Dennert R, van Suylen RJ, Waltenberger J, Leiner T, Wildberger J, Crijns HJ, Heymans S.

Eur J Heart Fail. 2010 Mar;12(3):227-31. doi: 10.1093/eurjhf/hfq004. No abstract available.

37.

Cardiac involvement in Churg-Strauss syndrome.

Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JW, Heymans S.

Arthritis Rheum. 2010 Feb;62(2):627-34. doi: 10.1002/art.27263.

38.

Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

van Rijsingen IA, Hermans-van Ast JF, Arens YH, Schalla SM, de Die-Smulders CE, van den Wijngaard A, Pinto YM.

Neth Heart J. 2009 Dec;17(12):458-63.

39.

Cardiomyocyte disintegration during Anderson-Fabry's disease.

Dennert R, Schalla S, Heymans S.

Eur Heart J. 2010 Apr;31(8):917. doi: 10.1093/eurheartj/ehp564. Epub 2009 Dec 11. No abstract available.

PMID:
20008338
40.

In vivo histology by cardiovascular magnetic resonance imaging.

Delnoij T, van Suylen RJ, Cleutjens JP, Schalla S, Bekkers SC.

Eur Heart J. 2009 Oct;30(20):2492. doi: 10.1093/eurheartj/ehp319. Epub 2009 Aug 20. No abstract available.

PMID:
19696188
41.

Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging.

Bekkers SC, Backes WH, Kim RJ, Snoep G, Gorgels AP, Passos VL, Waltenberger J, Crijns HJ, Schalla S.

Eur Radiol. 2009 Dec;19(12):2904-12. doi: 10.1007/s00330-009-1489-0.

42.

Giant cell myocarditis triggered by a parvovirus B19 infection.

Dennert R, Schalla S, Suylen RJ, Eurlings L, Heymans S.

Int J Cardiol. 2009 May 1;134(1):115-6. doi: 10.1016/j.ijcard.2007.12.020. Epub 2008 Feb 15.

PMID:
18280593
43.

Multivessel myocardial infarction.

Bekkers SC, Lemmert ME, Schalla S, Snoep R, Crijns HJ, Gorgels AP.

Neth Heart J. 2007 Dec;15(12):424-5. No abstract available.

44.

Magnetic resonance imaging of the coronary arteries.

Gerretsen SC, Kooi ME, Schalla S, Delhaas T, Snoep G, Van Engelshoven JM, Leiner T.

Cardiovasc J Afr. 2007 Jul-Aug;18(4):248-59. Review.

45.

Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy.

Herskind C, Schalla S, Hahn EW, Höver KH, Wenz F.

Radiat Prot Dosimetry. 2006;122(1-4):498-505. Epub 2007 Jan 12.

PMID:
17223644
46.

Protein-losing enteropathy in association with constrictive pericarditis.

Meijers BK, Schalla S, Eerens F, Van Suylen RJ, Broers B, Cheriex EM, Smedema JP.

Int J Cardiovasc Imaging. 2006 Jun-Aug;22(3-4):389-92. Epub 2006 Feb 25.

PMID:
16502021
47.

Left ventricular pseudoaneurysm.

Schalla S, Bär F, Mochtar B, Snoep G, Bekkers SC.

Eur Heart J. 2006 Apr;27(7):807. Epub 2005 Oct 24. No abstract available.

PMID:
16246836
48.

Long-term oral treatment with nicorandil prevents the progression of left ventricular hypertrophy and preserves viability.

Schalla S, Higgins CB, Saeed M.

J Cardiovasc Pharmacol. 2005 Apr;45(4):333-40.

PMID:
15772522
49.
50.

Myocardial perfusion imaging using OMNISCAN: a dose finding study for visual assessment of stress-induced regional perfusion abnormalities.

Paetsch I, Föll D, Langreck H, Herkommer B, Klein C, Schalla S, Fleck E, Nagel E.

J Cardiovasc Magn Reson. 2004;6(4):803-9.

PMID:
15646883

Supplemental Content

Loading ...
Support Center